PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.66%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
4.54%
Similar cost growth to CRON.TO's 4.61%. Walter Schloss would investigate if industry cost pressures are temporary.
-35.70%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-30.36%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-34.39%
R&D reduction while CRON.TO shows 6.51% growth. Joel Greenblatt would examine competitive risk.
-32.37%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
26.62%
Marketing expense growth above 1.5x CRON.TO's 11.37%. Michael Burry would check for spending discipline.
3334.27%
Other expenses growth above 1.5x CRON.TO's 9.13%. Michael Burry would check for concerning trends.
-15.52%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-4.39%
Both companies reducing total costs. Martin Whitman would check industry trends.
-2.26%
Interest expense reduction while CRON.TO shows 84.51% growth. Joel Greenblatt would examine advantage.
-26.23%
D&A reduction while CRON.TO shows 50.90% growth. Joel Greenblatt would examine efficiency.
65.77%
EBITDA growth exceeding 1.5x CRON.TO's 22.92%. David Dodd would verify competitive advantages.
62.93%
EBITDA margin growth while CRON.TO declines. John Neff would investigate advantages.
20.21%
Operating income growth exceeding 1.5x CRON.TO's 9.08%. David Dodd would verify competitive advantages.
13.59%
Operating margin growth exceeding 1.5x CRON.TO's 1.31%. David Dodd would verify competitive advantages.
341.00%
Other expenses growth 1.25-1.5x CRON.TO's 269.20%. Martin Whitman would scrutinize cost items.
100.42%
Pre-tax income growth exceeding 1.5x CRON.TO's 36.06%. David Dodd would verify competitive advantages.
100.46%
Pre-tax margin growth exceeding 1.5x CRON.TO's 30.60%. David Dodd would verify competitive advantages.
-219.09%
Both companies reducing tax expense. Martin Whitman would check patterns.
113.92%
Net income growth exceeding 1.5x CRON.TO's 37.71%. David Dodd would verify competitive advantages.
115.07%
Net margin growth exceeding 1.5x CRON.TO's 32.39%. David Dodd would verify competitive advantages.
99.57%
EPS growth exceeding 1.5x CRON.TO's 37.89%. David Dodd would verify competitive advantages.
99.57%
Diluted EPS growth exceeding 1.5x CRON.TO's 37.89%. David Dodd would verify competitive advantages.
2.42%
Share count reduction below 50% of CRON.TO's 0.27%. Michael Burry would check for concerns.
2.42%
Diluted share reduction below 50% of CRON.TO's 0.27%. Michael Burry would check for concerns.